Owner Scorecard


← All companies ← ROG Manual ROK → ← RLMD Pharmaceuticals RPRX →

ROIV, Roivant Sciences Ltd.

Pharmaceuticals consumer brand UnprofitableDistress / turnaroundCapital build-outNet current asset value

Roivant is a biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter.

We advance our pipeline by creating nimble subsidiaries or "Vants" to develop and commercialize our medicines and technologies.

Beyond therapeutics, Roivant also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.

Latest annual: FY2026 10-K
ROIV · Roivant Sciences Ltd.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2026
$8M
−71.6% YoY · −19% 5-yr CAGR
Vital signs · TTM
Cash & investments $4.3B
Cash burn · annual $750M
Runway 5.7 yrs

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Unprofitable. No meaningful revenue yet; the record is the cash on hand against the burn. Distress / turnaround. Thin interest coverage, or operating cash burned against real debt, across the record. The balance sheet carries this situation; the debt schedule sets the clock. Capital build-out. Capital spending has surged to 99% of sales, today's earnings are charged less depreciation than tomorrow's will be. Net current asset value. Current assets alone exceed every liability combined, and the surplus is most of the balance sheet: the shape Graham called a net-net.
What moves the needle
Operating margin has reached 13747% at its best but run negative through the cycle (median −3453%) — so the question is which reading is truer: whether the median was pulled below zero by one-off charges, by the cycle, or by spending it is still growing into, and whether it settles back at a profit. Stock-based pay runs about 691% of sales, a real and recurring claim on owners that the GAAP margin understates. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2021–2026

realized figures from each filing · older years to the left
2021’212022’222023’232024’242025’252026’26TTMTTMMar 2026
Income statement
$24M$55M$32M$33M$29M$8M$8MRevenueRevenue
n/mn/mn/mn/mn/mn/mn/mSG&A / revenueSG&A/rev
994%874%n/mn/mn/mn/mn/mR&D / revenueR&D/rev
($1.1B)($1.4B)($907M)$4.5B($1.0B)($515M)($515M)Operating incomeOp. inc.
n/mn/mn/mn/mn/mn/mn/mOperating marginOp. mgn
($809M)($845M)($1.0B)$4.3B($172M)($300M)($300M)Net incomeNet inc.
Cash flow & returns
($552M)($678M)($843M)($765M)($839M)($750M)($750M)Operating cash flowOp. cash
$6M$19M$22M$14M$3M$3MDepreciationDeprec.
$172M($403M)($71M)($5.3B)($971M)($800M)($800M)Working capital & otherWC & other
$6M$17M$13M$1M$5M$8M$8MCapexCapex
24.4%31.5%40.2%4.2%15.8%99.4%99.4%Capex / revenueCapex/rev
($558M)($695M)($856M)($767M)($844M)($759M)($759M)Owner earningsOwner earn.
n/mn/mn/mn/mn/mn/mn/mOwner earnings marginOE mgn
($558M)($695M)($856M)($767M)($844M)($759M)($759M)Free cash flowFCF
n/mn/mn/mn/mn/mn/mn/mFree cash flow marginFCF mgn
$0$0$1.3BBuybacksBuybacks
-40%-13%-12%ROICROIC
-45%-51%-87%73%-4%-7%-7%Return on equityROE
−45%−51%−87%73%−4%−7%−7%Retained to equityRetained/eq
Balance sheet
$2.1B$2.1B$1.7B$6.5B$4.9B$4.3B$4.3BCash & investmentsCash+inv
$4M$30M$54M$678KReceivablesReceiv.
$0$3M$35M$34MInventoryInvent.
$21M$35M$38M$14M$24M$18M$18MAccounts payablePayables
($31M)($5M)$75M$17MOperating working capitalOper. WC
$2.2B$2.1B$1.8B$6.7B$5.0B$5.2B$5.2BCurrent assetsCur. assets
$219M$184M$272M$267M$149M$281M$281MCurrent liabilitiesCur. liab.
10.0×11.6×6.6×25.2×33.5×18.4×18.4×Current ratioCurr. ratio
$2.6B$2.6B$2.4B$7.2B$5.4B$5.7B$5.7BTotal assetsAssets
$170M$210M$416M$443M$324MTotal debtDebt
($1.9B)($1.9B)($1.3B)($6.1B)($4.0B)Net debt / (cash)Net debt
-381.2×-192.0×-32.4×129.3×-13.1×Interest coverageInt. cov.
$1.8B$1.7B$1.2B$6.0B$4.7B$4.5B$4.5BShareholders’ equityEquity
357.0%n/m690.7%610.2%994.8%n/mn/mStock comp / revenueSBC/rev
Per share
630M670M713M831M725M694M694MShares out (diluted)Shares
$0.04$0.08$0.04$0.04$0.04$0.01$0.01Revenue / shareRev/sh
$-1.28$-1.26$-1.42$5.23$-0.24$-0.43$-0.43EPS (diluted)EPS
$-0.89$-1.04$-1.20$-0.92$-1.16$-1.09$-1.09Owner earnings / shareOE/sh
$-0.89$-1.04$-1.20$-0.92$-1.16$-1.09$-1.09Free cash flow / shareFCF/sh
$0.01$0.03$0.02$0.00$0.01$0.01$0.01Cap. spending / shareCapex/sh
$2.85$2.47$1.62$7.18$6.46$6.52$6.52Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
5-yr5-yr
Revenue / share−20.6%/yr−20.6%/yr
Capital spending / share+5.1%/yr+5.1%/yr
Book value / share+18.0%/yr+18.0%/yr

The record, charted

FY2021–2026

Each measure over its full record; the current point and the worst year marked.

Share count
694Mpeak FY2024

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

($759M)owner earningsvs.($300M)net incomelow FY2023

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2026 the business reported a $300M loss but ($759M) of owner earnings: $459M less than the profit line, taken out by capital spending and the timing of cash.

FY2026FY2025FY2024FY2023FY2022
Reported net income($300M)($172M)$4.3B($1.0B)($845M)
Depreciation & amortizationnon-cash charge added back+$3M+$14M+$22M+$19M+$6M
Stock-based compensationreal costnon-cash, but a real cost+$346M+$289M+$200M+$218M+$565M
Working capital & othertiming of cash in and out, other non-cash items−$800M−$971M−$5.3B−$71M−$403M
Cash from operations($750M)($839M)($765M)($843M)($678M)
Capital expenditurecash put back in to keep running and to grow−$8M−$5M−$1M−$13M−$17M
Owner earnings($759M)($844M)($767M)($856M)($695M)
Owner-earnings marginowner earnings ÷ revenue-9184%-2905%-2344%-2715%-1257%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $346M), owner earnings is nearer ($1.1B).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2026 10-K · source on SEC EDGAR →

Will it survive?

  • Does not cover its interest
    Operating income ($515M) ÷ interest expense $35M
    What this means

    A full year of operating profit didn't cover the interest bill. This is the zombie zone: the business depends on refinancing, asset sales, or forbearance to service its debt.

  • Net cash
    Cash $1.4B + ST investments $2.9B − debt $443M
    What this means

    Cash and short-term investments exceed every dollar of debt by $3.8B, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Below average
    NOPAT ($407M) ÷ invested capital $3.6B (debt + equity − cash)
    Industry peers: median -64%
    What this means

    The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.

  • Consumes cash through the cycle
    6-yr median margin, range -9184%–-1257%; latest ($759M) = operating cash ($750M) − maintenance capex $8M
    Industry peers: median -1243%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -9184% of revenue this year, a -2715% median across 6 years. Treating stock comp as the real expense it is (less $346M of SBC) leaves ($1.1B).

  • Loss, and burning cash
    Net income ($300M) · cash from operations ($750M)
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.

How is the cash used?

  • No surplus to allocate
    What this means

    The business didn't generate positive Owner Earnings this year, so any distributions came from the balance sheet or borrowing, not from operations.

  • Investing or harvesting? 2.45×
    Expanding
    Capex $8M ÷ depreciation $3M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 2 of 5 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $8M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 18.37×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $443M vs $4.9B WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (6-yr record) · 5 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · none paid
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $1.80/share (latest year $-0.42), the averaged base the calculator's gate runs on, and book value is $6.29/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2021–2026

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 1 of 6
    What this means

    Lost money in 5 year(s), look at what happened there before trusting the average.

  • Operating margin −3274% → 1353% (3-yr avg ends)
    What this means

    Through the cycle the operating margin widened — about −3274% early to 1353% lately, median −3453% — pricing power intact or improving.

  • Worst year 2026 · −6235.7% op. margin
    What this means

    Operations went underwater in 2026, understand why before trusting the good years.

  • Share count +1.9%/yr
    What this means

    The share count is rising, dilution works against you on a per-share basis.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

In its own filing A competitive risk, new this year

Its FY2026 10-K names artificial intelligence as a competitive threat, in language that was not in the prior year's filing.

“These AI-specific risks include, among others, model poisoning attacks in which adversaries corrupt or manipulate training data to cause AI models to produce incorrect or biased outputs, adversarial input attacks designed to manipulate model outputs in ways that are difficult to detect and model extraction attacks in w…”

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of fiscal year-end, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$5.2B
  • Cash & short-term investments$4.3B
  • Receivables$678K
  • Inventory$34M
  • Other current assets$841M
Current liabilities$281M
  • Debt due within a year$12M
  • Accounts payable$18M
  • Other current liabilities$251M
Current ratio18.37×all current assets ÷ what's due · Graham looked for 2×
Quick ratio18.25×stricter: inventory excluded
Cash ratio15.26×strictest: cash alone against what's due
Working capital$4.9Bthe cushion left after near-term bills
Debt due this year vs. cash$12M due · $4.3B cash covered by cash on hand, no refinancing forced · both figures from the Mar 31, 2026 balance sheet
Cash runway5.7 yrsthe business is consuming cash; this is how long the cash on hand lasts at that rate
Revenue, latest quarter vs. a year ago−77.8%the freshest read on whether the business is still growing
Current ratio, recent quarters27.9× → 18.4×
Deeper floors
Tangible book value$4.4Bequity stripped of goodwill & intangibles
Net current asset value$4.8BGraham's net-net: current assets less all liabilities
Debt incl. operating leases$431M$107M of it operating leases
Deferred revenue$15Mcustomer cash collected before delivery; operating float

From the company's latest filing.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2023Matthew Gline$49.0M$97.6M($856M)
2024Matthew Gline$738k$45.5M($767M)
2025Matthew Gline$163.3M$120.3M($844M)

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Stock-based compensation$346M

    The slice of the business handed to employees in shares this year, 4191% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why Roivant Sciences Ltd. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2021–2026.

2 of the 3 tests turned up something to look into; the other 1 came back clean.

  • Look hereDid debt outgrow the business?$170M → $324M

    Debt rose from $170M to $324M while owner earnings went from about ($703M) to ($790M): the borrowing grew and the earnings that would carry it are not there now. Debt raised for buybacks or deals rather than growth is the kind that bites in a downturn.

  • Look hereDid reported profit become cash?-3.65×

    Across the record the business reported $1.2B of net income but generated ($4.4B) of operating cash, a -3.65-to-one conversion. Profit that does not turn into cash over many years is the classic mark of earnings that are softer than they look. Ask where the gap sits, receivables, inventory, or costs being capitalized rather than expensed.

And these came back clean
  • Are "one-time" charges a yearly habit?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

What an owner would ask, FY2026

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Income taxes, Stock compensation as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
PGENPrecigen Inc.$10M-444.8%-72%-262%
ROIVRoivant Sciences Ltd.$8M-3164.6%-11%-2530%
COGTCogent Biosciences Inc.$8M-341.4%-48%-320%
CRNXCrinetics Pharmaceuticals Inc.$8M100%-5029.7%-46%-4079%
IMNMImmunome Inc.$7M-3228.8%-1243%
FATEFate Therapeutics Inc.$7M-834.6%-56%-744%
ABEOAbeona Therapeutics Inc.$6M74%-2313.2%-80%-1453%
PRMEPrime Medicine Inc.$5M-4498.1%-177%-3607%
Group median-2738.9%-56%-1348%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Roivant Sciences Ltd. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Revenue, delivered−19%/yr’21→’26

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−9184%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "Roivant Sciences Ltd. (ROIV), the owner's record," https://ownerscorecard.com/c/ROIV, data as of 2026-07-09.

Manual order: ← ROG its page in the Manual ROK →

Industry order: ← RLMD the Pharmaceuticals chapter RPRX →